Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21678 |
3MB-PP1
|
PLK | Cell Cycle/Checkpoint |
3MB-PP1是嘌呤类似物,是一种 Polo 样激酶 1 (Plk1) 抑制剂。在表达类似物敏感的 Plk1 等位基因的细胞中,3MB-PP1 通过靶向 Plk1 阻断有丝分裂进程和细胞分裂。3MB-PP1 特异性抑制类似物敏感的 Ssn3 (Cdk8)。3MB-PP1 抑制 Leu93 突变 Zipper-interacting protein kinase(Leu93-ZIPK),IC50为2 μM。3MB-PP1 可用于细胞分裂和白色念珠菌 (Candida albicans) 菌丝形成的研究。 | |||
TP2205L |
DAPK Substrate Peptide acetate
|
DAPK | Apoptosis |
DAPK Substrate Peptide acetate 是一种死亡相关蛋白激酶 (DAPK, Km = 9 μM) 肽底物。 | |||
T17004 |
TC-DAPK 6
|
DAPK | Apoptosis |
TC-DAPK 6 是死亡相关蛋白激酶 (DAPK) 的 ATP 竞争性抑制剂,对 DAPK1 和 DAPK3 的 IC50 分别为 69 和 225 nM。 | |||
TP2205 |
DAPK Substrate Peptide
|
Others | Others |
DAPK Substrate Peptide is a synthetic peptide substrate for death-associated protein kinase (DAPK) (Km = 9 μM). | |||
T75923 |
DAPK Substrate Peptide TFA
|
||
DAPKSubstrate Peptide TFA 是一种合成的死亡相关蛋白激酶 (DAPK) 的肽底物, Km 为 9 μM。 | |||
T61843 | CK156 | ||
CK156 is a potent inhibitor of death-associated protein kinase (DAPK), demonstrating high selectivity. In the DRAK1 NanoBRET assay, CK156 exhibits IC50 values of 182 nM, 34 μM, and 39 μM for DRAK1, CK2a1, and CK2a2, respectively. This compound is valuable for studying autoimmune and inflammatory diseases [1]. | |||
T80210 |
TAT-GluN2BCTM
|
DAPK | Apoptosis |
TAT-GluN2BCTM 是一种靶向DAPK1的膜透性肽,能够促使活性DAPK1定向降解于溶酶体。该化合物通过降低DAPK1的表达,有助于防护神经元免遭氧化应激和NMDAR-介导的兴奋毒性。TAT-GluN2BCTM常用于神经保护性研究领域。 |